Plain-English translation of NCT06863532 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 2 Diabetes research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether adding cofrogliptin—a new diabetes medication—works better than simply increasing the dose of metformin (a diabetes pill you may already be taking) for people whose blood sugar remains too high despite already taking two other diabetes medicines. You would be randomly assigned to either add the new medication or increase your metformin dose, and researchers will compare how well each approach controls your blood sugar over 24 weeks.
Many people with type 2 diabetes still struggle to control their blood sugar even when taking two medications together. This trial is trying to find out whether adding this medication is a better next step than just taking more of the metformin you may already be on.
You likely qualify if…
You likely don't qualify if…
You will visit the study clinic for screening and baseline tests, then be randomly assigned to either add the new medication to your current treatment or gradually increase your metformin dose. Over 24 weeks, you will have follow-up visits at 12 and 24 weeks where researchers will check your blood sugar, weight, and other health markers. You will need to check your blood sugar at home regularly, keep records, and maintain your usual diet and exercise habits throughout the study.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China